Journal of Child and Adolescent PsychopharmacologyPublished by Mary Ann Liebert Inc. An indispensable resource dedicated to delivering the most up-to-date information on the clinical and biological aspects of treating children and adolescents with psychotropic medications. |
|
| Audience | Psychiatrists, psychotherapists, clinicians, researchers and other professionals |
| Frequency | 6 issues a year: February, April, June, August, October, December |
| Editorial Focus | New developments in the diagnosis and treatment of ADHD, bipolar disorder, depression, anxiety, eating disorders, autism, and other disorders affecting children and adolescents—including clinical trials, clinical case reports, diagnostic studies, biological studies, genetics, and other biomedical aspects of child and adolescent psychiatric disorders. |
| Editor(s) in Chief | Harold J. Farber |
| Print Advertising Options | Adverts, Inserts & Supplements |
| Digital Advertising Options | Banners on website Banners on subscriber Table of Contents email alerts |
| Further Information | Heleen Vodégel Tel: +44 (0) 1875 825 700 hvodegel@impressmedia.com |
| Publisher | Journal of Child and Adolescent Psychopharmacology is owned and published by Mary Ann Liebert, Inc. Editorial headquarters: 140 Huguenot Street, New Rochelle, New York 10801, USA. Phone: +1 (914) 740-2100. Fax: +1 (914) 740-2101 www.liebertpub.com |
